MR编号 | DE/H/3112/006 |
---|
药品名称 | Temozolomid Fresenius Kabi 250 mg Hartkapseln |
---|
活性成分 | |
---|
剂型 | Capsule, hard |
---|
上市许可持有人 | Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
D-61352 Bad Homburg v.d.H. |
---|
参考成员国 - 产品名称 | Germany (DE) Temozolomid Fresenius Kabi 250 mg Hartkapseln |
---|
互认成员国 - 产品名称 | - Croatia (HR)
Temozolomid Fresenius Kabi 250 mg tvrde kapsule - Denmark (DK)
- Belgium (BE)
Temozolomide Fresenius Kabi 250 mg capsules, hard/gélules/Hartkapseln - Netherlands (NL)
- Iceland (IS)
- United Kingdom (GB)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Bulgaria (BG)
- Cyprus (CY)
TEMOZOLOMIDE FRESENIUS KABI 250mg HARD CAPS - Czechia (CZ)
Temozolomide Fresenius Kabi 250 mg - Estonia (EE)
- Hungary (HU)
TEMOZOLOMID Fresenius Kabi 5-20-100-140-180-250 mg kemény kapszula - Lithuania (LT)
Temozolomid Fresenius Kabi 250 mg kietosios kapsulės - Latvia (LV)
- Malta (MT)
Temozolomide Fresenius Kabi Capsules Hard 250mg - Poland (PL)
- Romania (RO)
Temozolamida Fresenius Kabi 250 mg capsule - Slovenia (SI)
- Slovakia (SK)
|
---|
许可日期 | 2014/08/06 |
---|
最近更新日期 | 2016/02/24 |
---|
药物ATC编码 | 申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
|
---|